Page 245 - Small Animal Internal Medicine, 6th Edition
P. 245

CHAPTER 11   Systemic Arterial Hypertension   217



                   TABLE 11.1
  VetBooks.ir  Drugs Used to Treat Hypertension DOG                              CAT

             DRUG

             ACEIs (see Chapter 3)
             Enalapril                  0.5 mg/kg PO q12h                        0.5 mg/kg PO q24h
             Benazepril                 0.5 mg/kg PO q12h                        Same
             Ramipril                   0.125-0.25 mg/kg PO q24h                 0.125 mg/kg PO q24h
             Captopril                  0.5-2 mg/kg PO q8-12h                    0.5-1.25 mg/kg PO q(8-)24h

             Calcium Channel Blocker
             Amlodipine                 0.1-0.3 (up to 0.5) mg/kg PO q24(-12)h   0.625 mg/cat (or 0.1-0.2 [up to 0.5]
                                                                                   mg/kg) PO q(-12)24h
             β-Adrenergic Blockers (see Chapter 4)
             Atenolol                   0.2-1 mg/kg PO q12(-24)h (start low)     6.25-12.5 mg/cat PO q12(-24)h
             Propranolol                0.1-1 mg/kg PO q8h (start low)           2.5-10 mg/cat PO q8-12h
             α 1 -Adrenergic Blockers
             Phenoxybenzamine           0.25 mg/kg PO q8-12h or 0.5 mg/kg q24h   2.5 mg/cat PO q8-12h or 0.5 mg/kg
                                                                                   q12-24h
             Prazosin                   0.05-0.2 mg/kg PO q8-12h                 0.25-0.5 mg/cat PO q12-24h
             Drugs for Hypertensive Crisis
             Amlodipine                 0.1-0.3 (up to 0.5) mg/kg PO q24(-12)h   0.625 mg/cat (or 0.1-0.2 [up to 0.5]
                                                                                   mg/kg) PO q(-12)24h
             Hydralazine (see Chapter 3)  0.5-2 mg/kg PO q12h (start low, titrate up to   Same (or 2.5 [up to 10] mg/cat PO
                                          effect); or 0.1-0.2 mg/kg, IV or IM, repeat   q12h)
                                          q2h as needed
             Nitroprusside (see Chapter 3)  0.5-1 mcg/kg/min CRI (initial) to 5-15 mcg/  0.5-1 mcg/kg/min CRI (initial), to
                                          kg/min CRI                               5 mcg/kg/min CRI
             Esmolol                    25-75 (up to 200) mcg/kg/min CRI         Same
             Propranolol                0.02 mg/kg (initial) to max of 0.1 mg/kg slow   Same
                                          IV
             Acepromazine               0.05-0.1 mg/kg (up to 3 mg total) IV     0.01-0.05 mg/kg IV
             Phentolamine               0.02-0.1 mg/kg IV bolus, followed by CRI to   Same
                                          effect

            ACEI, Angiotensin-converting enzyme inhibitor; CRI, constant-rate infusion; IV, intravenous; PO, by mouth.


            be tried. Continued attention to the underlying disease   steroids, and erythropoietin) can exacerbate hypertension or
            process is important. Routine CBC, serum biochemistry   complicate its control. Target-organ damage from systemic
            profile,  and  urinalysis  (with  UPC)  are  also  recommended   hypertension could improve or reverse once patients become
            every 6 months. Other tests are done as indicated. Decreas-  normotensive. Retinal hemorrhage generally resolves and
            ing the magnitude of proteinuria associated with hyperten-  detached retinas may reattach, although prognosis for vision
            sion is a desired treatment outcome, as degree of proteinuria   remains guarded. Reverse remodeling of LV hypertrophy can
            is a negative prognostic factor in cats with CKD.    occur. Adequate control of BP also is thought to decrease the
              The long-term prognosis for animals with hypertension   rate of progression of CKD.
            reflects prognosis for the underlying disease, which may
            be chronic and progressive. Unfortunately, hypertension   ANTIHYPERTENSIVE DRUGS
            often persists even with adequate treatment or control of   The ACEIs (e.g., enalapril, benazepril) reduce angiotensin
            the underlying disease, particularly in dogs with hyperad-  II production, thereby reducing vascular resistance and
            renocorticism and cats with hyperthyroidism. In addition,   volume retention (see  p. 67). These agents also selectively
            therapy for some primary diseases (such as fluid therapy,   dilate the glomerular efferent arteriole and thus decrease
   240   241   242   243   244   245   246   247   248   249   250